{"disease":{"id":"mild-alzheimer-disease","name":"mild alzheimer disease"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04701177","title":"Digitally-enhanced, Decentralized, Multi-omics Observational Cohort","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":100000,"lead_sponsor_name":"Greece 2021 Committee","has_results":false},{"nct_id":"NCT03653156","title":"China Cognition and Aging Study","phase":"","overall_status":"RECRUITING","enrollment_count":100000,"lead_sponsor_name":"Capital Medical University","has_results":false},{"nct_id":"NCT03672448","title":"The China Longitudinal Aging Study of Cognitive Impairment","phase":"","overall_status":"UNKNOWN","enrollment_count":10000,"lead_sponsor_name":"Shanghai Mental Health Center","has_results":false},{"nct_id":"NCT06058234","title":"Medicare Anti-Aβ mAb Coverage With Evidence Development (CED) Study","phase":"","overall_status":"RECRUITING","enrollment_count":8680,"lead_sponsor_name":"Centers for Medicare and Medicaid Services/ Coverage and Analysis Group","has_results":false},{"nct_id":"NCT06889818","title":"Korean Joint Registry for Alzheimer's Treatment and Diagnostics (JOY-ALZ)","phase":"","overall_status":"RECRUITING","enrollment_count":4000,"lead_sponsor_name":"Ewha Womans University Mokdong Hospital","has_results":false},{"nct_id":"NCT01931566","title":"Biomarker Qualification for Risk of Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease (AD) and Safety and Efficacy Evaluation of Pioglitazone in Delaying Its Onset","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":3494,"lead_sponsor_name":"Takeda","has_results":true},{"nct_id":"NCT07016178","title":"Innovative Cognitive Impairment Case Finding and Engagement for Diverse Participation in Alzheimer's Disease Care, Treatment, And Research","phase":"NA","overall_status":"COMPLETED","enrollment_count":3454,"lead_sponsor_name":"Indiana University","has_results":false},{"nct_id":"NCT05617014","title":"Alzheimer's Disease Neuroimaging Initiative 4","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":1500,"lead_sponsor_name":"University of Southern California","has_results":false},{"nct_id":"NCT01953601","title":"Efficacy and Safety Trial of Verubecestat (MK-8931) in Participants With Prodromal Alzheimer's Disease (MK-8931-019)","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":1454,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT06122415","title":"The Swedish BioFINDER - Memory Clinic Study","phase":"","overall_status":"RECRUITING","enrollment_count":1200,"lead_sponsor_name":"Skane University Hospital","has_results":false},{"nct_id":"NCT06120361","title":"The Swedish BioFINDER - Primary Care Study","phase":"","overall_status":"RECRUITING","enrollment_count":1200,"lead_sponsor_name":"Skane University Hospital","has_results":false},{"nct_id":"NCT01231971","title":"Alzheimer's Disease Neuroimaging Initiative 2","phase":"","overall_status":"COMPLETED","enrollment_count":1182,"lead_sponsor_name":"University of Southern California","has_results":false},{"nct_id":"NCT02854033","title":"Alzheimer's Disease Neuroimaging Initiative 3","phase":"","overall_status":"COMPLETED","enrollment_count":1141,"lead_sponsor_name":"University of Southern California","has_results":false},{"nct_id":"NCT02293915","title":"An Efficacy and Safety Study of Sodium Oligo-mannurarate (GV-971) Capsule for the Treatment of Alzheimer's Disease","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":818,"lead_sponsor_name":"Shanghai Greenvalley Pharmaceutical Co., Ltd.","has_results":false},{"nct_id":"NCT07214974","title":"Mild Cognitive Impairment Community Screening and Early Intervention Via Stem Cell Therapy and Wearable Brain Computer Interface Device.","phase":"EARLY_PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":600,"lead_sponsor_name":"Noah Tech, Corp.","has_results":false},{"nct_id":"NCT07041450","title":"Screening for Anti-amyloid Treatment Eligibility Using Digital Cognition and Blood-based Biomarkers","phase":"","overall_status":"RECRUITING","enrollment_count":500,"lead_sponsor_name":"MoCA Clinic and Institute","has_results":false},{"nct_id":"NCT03834402","title":"INTERCEPTOR Project: From MCI to Dementia","phase":"","overall_status":"COMPLETED","enrollment_count":500,"lead_sponsor_name":"Catholic University of the Sacred Heart","has_results":false},{"nct_id":"NCT06793735","title":"Effectiveness of TeleVR App in Cognitive Decline and MCI Patients","phase":"NA","overall_status":"RECRUITING","enrollment_count":480,"lead_sponsor_name":"IRCCS Centro Neurolesi Bonino Pulejo","has_results":false},{"nct_id":"NCT05399888","title":"A Study to Learn About the Safety of BIIB080 Injections and Whether They Can Improve Symptoms of Participants With Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild AD Dementia Between 50 to 80 Years of Age","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":416,"lead_sponsor_name":"Biogen","has_results":false},{"nct_id":"NCT05569083","title":"PRedicting the EVolution of SubjectIvE Cognitive Decline to Alzheimer's Disease With Machine Learning","phase":"","overall_status":"UNKNOWN","enrollment_count":350,"lead_sponsor_name":"Azienda Ospedaliero-Universitaria Careggi","has_results":false},{"nct_id":"NCT07422857","title":"Evaluate the Use of [18F]-APN-1607 PET in Subjects With AD-related Cognitive Impairment and Subjects With Normal Cognitive Function","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":316,"lead_sponsor_name":"JYAMS PET Research & Development Limited","has_results":false},{"nct_id":"NCT05811000","title":"A Phase 2 Clinical Study to Explore the Optimal Dosage/Administration of PM012 Tablet in Alzheimer's Disease","phase":"PHASE2, PHASE3","overall_status":"UNKNOWN","enrollment_count":312,"lead_sponsor_name":"Mediforum Ltd., Co.","has_results":false},{"nct_id":"NCT06182085","title":"Study to Assess Safety and Efficacy of PRI-002 in Patients With MCI to Mild Dementia Due to Alzheimer's Disease (AD)","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":304,"lead_sponsor_name":"PRInnovation GmbH","has_results":false},{"nct_id":"NCT05803122","title":"Validation of the I-UDS Neuropsychological Battery","phase":"","overall_status":"COMPLETED","enrollment_count":252,"lead_sponsor_name":"IRCCS National Neurological Institute \"C. Mondino\" Foundation","has_results":false},{"nct_id":"NCT03069014","title":"Study of LM11A-31-BHS in Mild-moderate AD Patients","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":242,"lead_sponsor_name":"PharmatrophiX Inc.","has_results":false},{"nct_id":"NCT05795634","title":"Cognitive Vulnerability to Stress in Individuals at Risk for Alzheimer's Disease","phase":"NA","overall_status":"RECRUITING","enrollment_count":240,"lead_sponsor_name":"Johns Hopkins University","has_results":false},{"nct_id":"NCT01767909","title":"The Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF)","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":240,"lead_sponsor_name":"University of Southern California","has_results":true},{"nct_id":"NCT05542953","title":"[18F]APN-1607 PET in Subjects With AD Compared to HC","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":230,"lead_sponsor_name":"APRINOIA Therapeutics","has_results":false},{"nct_id":"NCT04206670","title":"In-Home Technology for Caregivers of People With Dementia and Mild Cognitive Impairment","phase":"NA","overall_status":"COMPLETED","enrollment_count":216,"lead_sponsor_name":"University of California, Berkeley","has_results":true},{"nct_id":"NCT05877196","title":"A SMART Trial of Adaptive Exercises to Optimize Aerobic-Fitness Responses","phase":"NA","overall_status":"RECRUITING","enrollment_count":216,"lead_sponsor_name":"Arizona State University","has_results":false},{"nct_id":"NCT03625622","title":"Efficacy and Safety of 26-Week Treatment of AR1001 in Patients With Mild to Moderate Alzheimer's Disease","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":210,"lead_sponsor_name":"AriBio Co., Ltd.","has_results":false},{"nct_id":"NCT06335836","title":"The Effects of Social Isolation and Social Interaction on the Risk of Dementia Progression and Brain Function in SCD (Subjective Cognitive Decline, SCD)","phase":"","overall_status":"RECRUITING","enrollment_count":209,"lead_sponsor_name":"The First Affiliated Hospital with Nanjing Medical University","has_results":false},{"nct_id":"NCT07294586","title":"Exploratory Clinical Study and Validation of Blood Biomarkers for Alzheimer's Disease","phase":"","overall_status":"COMPLETED","enrollment_count":200,"lead_sponsor_name":"Amoneta Diagnostics SAS","has_results":false},{"nct_id":"NCT05122598","title":"Development and Evaluation of Computerized Olfactory Training Program for Cognitive Decline in Early Alzheimer's Disease","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":200,"lead_sponsor_name":"Evon Medics LLC","has_results":false},{"nct_id":"NCT06362707","title":"Fasudil Trial for Treatment of Early Alzheimer's Disease (FEAD)","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"Helse Stavanger HF","has_results":false},{"nct_id":"NCT02702817","title":"Randomized Trial of Low-dose Naproxen in Cognitively Intact Persons at Risk of Alzheimer's Dementia","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":200,"lead_sponsor_name":"Douglas Mental Health University Institute","has_results":false},{"nct_id":"NCT05189210","title":"GV1001 Subcutaneous(SC) for the Treatment of Mild to Moderate Alzheimer's Disease (AD)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":199,"lead_sponsor_name":"GemVax & Kael","has_results":false},{"nct_id":"NCT04784416","title":"Transcranial Photobiomodulation for Alzheimer's Disease (TRAP-AD)","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":196,"lead_sponsor_name":"NYU Langone Health","has_results":false},{"nct_id":"NCT06826157","title":"The Role of Advanced Electroencephalographic Data as Marker of Pathology and Prognosis in Primary Dementias","phase":"NA","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":175,"lead_sponsor_name":"IRCCS San Raffaele","has_results":false},{"nct_id":"NCT05619692","title":"A Study to Evaluate the Effects of SAGE-718 in Participants With Mild Cognitive Impairment or Mild Dementia Due to Alzheimer's Disease (AD)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":174,"lead_sponsor_name":"Supernus Pharmaceuticals, Inc.","has_results":true},{"nct_id":"NCT03486938","title":"Study of AGB101 in Mild Cognitive Impairment Due to Alzheimer's Disease","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":164,"lead_sponsor_name":"AgeneBio","has_results":true},{"nct_id":"NCT05640141","title":"Pre-demential Motoric Cognitive Risk Syndrome in Ageing Subjects","phase":"","overall_status":"UNKNOWN","enrollment_count":160,"lead_sponsor_name":"University Hospital, Caen","has_results":false},{"nct_id":"NCT06385951","title":"Spatial Navigation for the Early Detection of Alzheimer's Disease.","phase":"NA","overall_status":"RECRUITING","enrollment_count":160,"lead_sponsor_name":"University Hospital, Ghent","has_results":false},{"nct_id":"NCT03507790","title":"A Study to Evaluate the Safety and Efficacy of CT1812 in Subjects With Mild to Moderate Alzheimer's Disease.","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":153,"lead_sponsor_name":"Cognition Therapeutics","has_results":true},{"nct_id":"NCT06994767","title":"Speech-derived Digital Biomarkers Study","phase":"NA","overall_status":"COMPLETED","enrollment_count":150,"lead_sponsor_name":"Hackensack Meridian Health","has_results":false},{"nct_id":"NCT05108922","title":"A Study of Donanemab (LY3002813) Compared With Aducanumab in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ 4)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":148,"lead_sponsor_name":"Eli Lilly and Company","has_results":true},{"nct_id":"NCT05417555","title":"Low Intensity Focused Ultrasound for Mild Cognitive Impairment and Mild Alzheimer's Disease","phase":"NA","overall_status":"RECRUITING","enrollment_count":144,"lead_sponsor_name":"University of California, Los Angeles","has_results":false},{"nct_id":"NCT06083350","title":"Effects of Yeast Beta-glucan on Cognitive Function in Patients With Mild Cognitive Impairment","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":144,"lead_sponsor_name":"Xiaofan Xu","has_results":false},{"nct_id":"NCT03444181","title":"ALzheimer and MUsic THerapy: Effects of Music Lessons on Brain Plasticity, Mood, and Quality of Life in Alzheimer Patients","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":136,"lead_sponsor_name":"University of Bergen","has_results":false},{"nct_id":"NCT03461276","title":"Safety and Immunogenicity of Repeated Doses of ABvac40 in Patients With a-MCI or Vm-AD","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":134,"lead_sponsor_name":"Araclon Biotech S.L.","has_results":true}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}